Sovereign wealth funds are making some big entrances and exits in the Asia-Pacific with bids closing in QIC-owned oncology player Icon Group and Singapore's GIC acquiring a minority stake in Sunway hospital group Sunway Healthcare.
HBI understands that Malaysian/Indonesian hospital group Ramsay Sime Darby has appointed banks for a $300m IPO. One side of the JV says that expansion in healthcare is a key strategic focus, the other appears notably quiet about its investment in Asia. FY2020 saw profits drop for "the first time in many years" as COVID struck.
HBI State of the Regions continued on Tuesday morning with a look at SE Asia. It's "overloaded" in some parts with "substantial coverage gaps" in others, with big provider/payor conflict in most. Eduardo Banzon from the Asian Development Bank, Cole Sirucek from DocDoc, and Angus Slater from Bupa talk about the biggest challenges and opportunities on the continent.
Chinese private hospital operator Guodan Healthcare has refiled plans to IPO on the Hong Kong exchange and, if successful, will become the twelfth Chinese hospital in the country to list. But it's a crowded space and most of the 11 other stocks have underperformed in the last four years as our infographic shows.
Singapore-based 'doctor discovery platform' DocDoc has moved into China through a partnership with one of the world's largest insurance risk management companies, Kaitaiming (KTM), giving it access to 90% of the country's insurers. HBI speaks to CEO Cole Sirucek.
HBI speaks to Hong-Kong-based insure tech startup CareVoice about how its solution supports insurers to deliver more bespoke plans in China, following its $10m Series A. As most global insurers are trying to pivot from being gatekeepers to caregivers, can solutions that provide preventative support help?
Pan-Asian hospital group IHH Healthcare has announced its CEO will change at the end of 2019, a refinancing of up to $250m of non-Lira debt and its Fortis deal boosted Q1 2019 results, while its Turkish subsidiary Acibadem is reportedly eyeing an investment in London.
Pan-Asian hospital group IHH Healthcare saw 3% revenue growth, 9% EBITDA growth but a 35% plummet in post-tax profits in 2018. The results confirm its struggles in Turkey.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.